Role of toll-like receptor 4 in colorectal carcinogenesis: A meta-analysis

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Li, Xiao Xia ^a   Sun, Gong Ping ^a   Meng, Jin ^a   Li, Xin ^a   Tang, Yuan Xin ^a   Li, Zhen ^a   Wang, Mo Fei ^a   Liang, Gao Feng ^a   Lu, Xiao Bo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; TOLL LIKE RECEPTOR 4;

ALLELE; ARTICLE; ASIAN; CANCER RISK; CARCINOGENESIS; CAUCASIAN; COLORECTAL CANCER; ETHNICITY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; HUMAN; NEGRO; PROTEIN EXPRESSION; PROTEIN FUNCTION; SYSTEMATIC REVIEW; TLR 4 GENE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; GENETICS; META ANALYSIS; METABOLISM; RISK; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOGENESIS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, MESSENGER; TOLL-LIKE RECEPTOR 4;

EID: 84899428429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093904     Document Type: Article

References (46)

1. Stein KB, Snyder CF, Barone BB, Yeh HC, Peairs KS, et al. (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci, 55(7): 1839-1851.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al (2011) Global cancer statistics. CA Cancer J Clin, 61(2): 69-90.
3. Spiller RC, Thompson WG (2010) Bowel disorders. Am J Gastroenterol, 105(4): 775-785.
4. Mlecnik B, Tosolini M, Charoentong P, Kirilovsky A, Bindea G, et al. (2010) Biomolecular network reconstruction identifies T-cell homing factors associated with survival in colorectal cancer. Gastroenterology, 138(4): 1429-1440.
5. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer, 125(1): 171-180.
6. Sartore-Bianchi A, Martini M, Molinari F, Veronese S, Nichelatti M, et al. (2009) PIK3CA mutations in colorectal cancer are associated with clinical resistance to EGFR-targeted monoclonal antibodies. Cancer Res, 69(5): 1851-1857.
7. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, et al. (2009) Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer, 9(7): 489-499.
8. Kutikhin AG (2011) Impact of Toll-like receptor 4 polymorphisms on risk of cancer. Hum Immunol, 72(2): 193-206.
9. Horie Y, Meguro A, Ota M, Kitaichi N, Katsuyama Y, et al. (2009) Association of TLR4 polymorphisms with Behcet's disease in a Korean population. Rheumatology (Oxford), 48(6): 638-642.
10. Omrane I, Baroudi O, Kourda N, Bignon YJ, Uhrhammer N, et al. (2014) Positive link between variant Toll-like receptor 4 (Asp299Gly and Thr399Ile) and colorectal cancer patients with advanced stage and lymph node metastasis. Tumour Biol, 35: 545-551.
11. Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A (2010) The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int, 4(4): 659-672.
12. Hormannsperger G, Haller D (2010) Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. Int J Med Microbiol, 300(1): 63-73.
13. Pimentel-Nunes P, Teixeira AL, Pereira C, Gomes M, Brandao C, et al. (2013) Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis, 45(1): 63-69.
14. Davoodi H, Seow HF (2011) Variant Toll-like receptor4 (Asp299Gly and Thr399Ile alleles) and Toll-like receptor2 (Arg753Gln and Arg677Trp alleles) in colorectal cancer. Iran J Allergy Asthma Immunol, 10(2): 91-99.
15. Xu Y, Xu Q, Yang L, Liu F, Ye X, et al. (2013) Gene expression analysis of peripheral blood cells reveals Toll-like receptor pathway deregulation in colorectal cancer. PLoS One, 8(5): e62870.
16. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, et al. (2010) High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer, 102(5): 908-915.
17. Moossavi S, Rezaei N (2013) Toll-like receptor signalling and their therapeutic targeting in colorectal cancer. Int Immunopharmacol 16(2): 199-209.
18. Boraska Jelavic T, Barisic M, Drmic Hofman I, Boraska V, Vrdoljak E, et al. (2006) Microsatelite GT polymorphism in the toll-like receptor 2 is associated with colorectal cancer. Clin Genet, 70(2): 156-160. (Pubitemid 44028102)
19. Stang A (2010) Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol, 25(9): 603-605.
20. Zintzaras E, Ioannidis JP (2005) HEGESMA: genome search meta-analysis and heterogeneity testing. Bioinformatics, 21(18): 3672-3673. (Pubitemid 41264106)
21. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2006) Comparison of two methods to detect publication bias in meta-analysis. JAMA, 295(6): 676-680. (Pubitemid 43209069)
22. Dai Q, Zhong L, Zhang X, Yang ZH (2012) Expression of IL-1α and TNF-α modified by Toll-like receptor 4 genetic polymorphism is associated with colorectal carcinoma. Chin J Pathpphysiol, 28(11): 1976-1978.
23. Yang GG, Qiu JM, Wang X, Shen Z, Shao SX, et al. (2011) Variant Toll-like receptor 4 in colorectal cancer. Chin J Gastrointestin Surg, 14(10): 814-815.
24. Cheng ZL, Li XM, Yang TT, Zhu Q (2012) Expression of TLR 4 in colorectal cancer and its relationships with FasL and EGFR. J Shandong Univ (Health Sci), 50(5): 92-94,98.
25. Guo YW, Wen ZF, Zheng FP (2007) Expression of TLR2 and TLR4in colorectal carcinoma. Guangdong Med J, 28(9): 1435-1437.
26. Hu KF, Chang JC, Liu Y, Zhu JS, Zhou ZY, et al. (2013) Expressions of TLR4 and TLR9 in Colorectal Carcinoma Tissues. J Basic Clin Oncol, 26(3): 198-201.
27. Huang HY, Y CW, Liu FF, Zhang QY, Li XZ, et al. (2010) The expression and correlation of TLR4 and NF-κB p65 in colorectal carcinoma. Chin J Labor Med, 33(10): 953-957.
28. Jin HM, Meng QY (2009) A study on the expression of TLR4 in humen colorental cancer by RT-PCR. Modern Practic Med, 21(7): 682-684.
29. Nihon-Yanagi Y, Terai K, Murano T, Matsumoto T, Okazumi S (2012) Tissue expression of Toll-like receptors 2 and 4 in sporadic human colorectal cancer. Cancer Immunol Immunother, 61(1): 71-77.
30. Tian F, Zhang L, Guo QX, Cui B, Zhang J, et al. (2008) Expression and significance of heme oxygenase-1 and Toll-like receptor 2/4 in rectal carcinoma. Chin J Current Adv Gener Surg, 11(3): 248-250,254.
31. Yu YH, Qian L, Chen W (2011) Toll-like receptor4 mRNA and myeloid differentiation factor 88 in colorectal cancer. Hainan Med J, 22(12): 9-11.
32. Kang JY, Lee JO (2011) Structural biology of the Toll-like receptor family. Annu Rev Biochem, 80: 917-941.
33. Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol, 21(4): 317-337.
34. Kawai T, Akira S (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol, 11(5): 373-384.
35. Yu L, Wang L, Li M, Zhong J, Wang Z, et al. (2010) Expression of toll-like receptor 4 is down-regulated during progression of cervical neoplasia. Cancer Immunol Immunother, 59(7): 1021-1028.
36. Lagos D, Vart RJ, Gratrix F, Westrop SJ, Emuss V, et al. (2008) Toll-like receptor 4 mediates innate immunity to Kaposi sarcoma herpesvirus. Cell Host Microbe, 4(5): 470-483.
37. Eissmann P, Evans JH, Mehrabi M, Rose EL, Nedvetzki S, et al. (2010) Multiple mechanisms downstream of TLR-4 stimulation allow expression of NKG2D ligands to facilitate macrophage/NK cell crosstalk. J Immunol, 184(12): 6901-6909.
38. Iwasaki A, Medzhitov R (2010) Regulation of adaptive immunity by the innate immune system. Science, 327(5963): 291-295.
39. Gorina R, Font-Nieves M, Marquez-Kisinousky L, Santalucia T, Planas AM (2011) Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways. Glia, 59(2): 242-255.
40. Cario E (2010) Toll-like receptors in inflammatory bowel diseases: a decade later. Inflamm Bowel Dis, 16(9): 1583-1597.
41. Slattery ML, Herrick JS, Bondurant KL, Wolff RK (2012) Toll-like receptor genes and their association with colon and rectal cancer development and prognosis. Int J Cancer, 130(12): 2974-2980.
42. Lee JY, Plakidas A, Lee WH, Heikkinen A, Chanmugam P, et al. (2003) Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res, 44(3): 479-486. (Pubitemid 37279695)
43. Thomas KH, Meyn P, Suttorp N (2006) Single nucleotide polymorphism in 5′-flanking region reduces transcription of surfactant protein B gene in H441 cells. Am J Physiol Lung Cell Mol Physiol 291(3): L386-390. (Pubitemid 44343714)
44. Hunt R, Sauna ZE, Ambudkar SV, Gottesman MM, Kimchi-Sarfaty C (2009) Silent (synonymous) SNPs: should we care about them? Methods Mol Biol 578: 23-39.
45. Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, et al. (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14(5-6): 346-352. (Pubitemid 351785708)
46. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology, 133(6): 1869-1881.